TITLE

Mitochondrial Network Genes in the Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients

AUTHOR(S)
Bernardini, Camilla; Censi, Federica; Lattanzi, Wanda; Barba, Marta; Calcagnini, Giovanni; Giuliani, Alessandro; Tasca, Giorgio; Sabatelli, Mario; Ricci, Enzo; Michetti, Fabrizio
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recent evidence suggested that muscle degeneration might lead and/or contribute to neurodegeneration, thus it possibly play a key role in the etiopathogenesis and progression of amyotrophic lateral sclerosis (ALS). To test this hypothesis, this study attempted to categorize functionally relevant genes within the genome-wide expression profile of human ALS skeletal muscle, using microarray technology and gene regulatory network analysis. The correlation network structures significantly change between patients and controls, indicating an increased inter-gene connection in patients compared to controls. The gene network observed in the ALS group seems to reflect the perturbation of muscle homeostasis and metabolic balance occurring in affected individuals. In particular, the network observed in the ALS muscles includes genes (PRKR1A, FOXO1, TRIM32, ACTN3, among others), whose functions connect the sarcomere integrity to mitochondrial oxidative metabolism. Overall, the analytical approach used in this study offer the possibility to observe higher levels of correlation (i.e. common expression trends) among genes, whose function seems to be aberrantly activated during the progression of muscle atrophy.
ACCESSION #
87625627

 

Related Articles

  • The non-cell-autonomous component of ALS: new in vitro models and future challenges. Ferraiuolo, Laura // Biochemical Society Transactions;Oct2014, Vol. 42 Issue 5, p1270 

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder affecting the motor nerves. At present, there is no effective therapy for this devastating disease and only one Food and Drug Administration (FDA)-approved drug, riluzole, is known to moderately extend survival. In the...

  • Regulation of FMO and PON Detoxication Systems in ALS Human Tissues. Gagliardi, Stella; Abel, Kenneth; Bianchi, Marika; Milani, Pamela; Bernuzzi, Stefano; Corato, Manuel; Ceroni, Mauro; Cashman, John; Cereda, Cristina // Neurotoxicity Research;May2013, Vol. 23 Issue 4, p370 

    Amyotrophic lateral sclerosis (ALS) is an adult-onset, progressive, and fatal neurodegenerative disease with unknown etiology. Recent evidence suggests an association between the exposure to toxic environmental factors and sporadic ALS. The flavin-containing monooxygenases (FMOs) and paraoxonase...

  • Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity. Dodge, James C.; Haidet, Amanda M.; Yang, Wendy; Passini, Marco A.; Hester, Mark; Clarke, Jennifer; Roskelley, Eric M.; Treleaven, Christopher M.; Rizo, Liza; Martin, Heather; Kim, Soo H.; Kaspar, Rita; Taksir, Tatyana V.; Griffiths, Denise A.; Cheng, Seng H.; Shihabuddin, Lamya S.; Kaspar, Brian K. // Molecular Therapy;Jun2008, Vol. 16 Issue 6, p1056 

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of the motor system. Recent work in rodent models of ALS has shown that insulin-like growth factor-1 (IGF-1) slows disease progression when delivered at disease onset. However, IGF-1's mechanism of action along the...

  • The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosis. Lovejoy, David B.; Guillemin, Gilles J. // Frontiers in Aging Neuroscience;Jul2014, Vol. 6, p1 

    Modulations of the potentially toxic transition metals iron (Fe) and copper (Cu) are implicated in the neurodegenerative process in a variety of human disease states including amyotrophic lateral sclerosis (ALS). However, the precise role played by these metals is still very much unclear,...

  • Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis. Costa, Júlia; Gomes, Catarina; de Carvalho, Mamede // CNS & Neurological Disorders - Drug Targets;Dec2010, Vol. 9 Issue 6, p764 

    Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease of the motor system. The diagnosis is clinical, but additional investigations such as electromyography, transcranial magnetic stimulation and neuroimaging have demonstrated their usefulness in supporting diagnosis....

  • A Novel Acylaminoimidazole Derivative, WN1316, Alleviates Disease Progression via Suppression of Glial Inflammation in ALS Mouse Model. Tanaka, Kazunori; Kanno, Takuya; Yanagisawa, Yoshiko; Yasutake, Kaori; Inoue, Satoshi; Hirayama, Noriaki; Ikeda, Joh-E // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Amyotrophic lateral sclerosis (ALS) is an adult-onset motor neuron degenerative disease. Given that oxidative stress and resulting chronic neuronal inflammation are thought to be central pathogenic, anti-oxidative agents and modulators of neuronal inflammation could be potential therapies for...

  • Slowing Down ALS.  // PN;Nov2013, Vol. 67 Issue 11, p19 

    The article discusses studies of a therapy conducted by a group of researchers from Ohio and California that dramatically slows down the onset and progression of amyotrophic lateral sclerosis (ALS). It says that the study included analysis of two different models treated before and after disease...

  • Amyotrophe Lateralsklerose -- Abklärung und Therapie. Jung, H. H.; Neumann, M.; Bloch, K. E. // Praxis (16618157);7/18/2012, Vol. 101 Issue 14, p907 

    Amyotrophic lateral sclerosis (ALS) represents the most common motoneuron disorder in adulthood. It is characterized by selective degeneration of the motoneurons. About 10% of patients have a genetically determined ALS. Clinically, ALS is characterized by coexistence of signs of the first...

  • 28: Lithium Treatment for ALS. Bosveld, Jane // Discover;Jan2009, Vol. 30 Issue 1, p40 

    The article discusses research which suggests that treatment for amyotrophic lateral sclerosis (ALS) may be improved by incorporating a drug which contains riluzole and lithium. Lithium has been found to counteract the damage of motor neurons and stimulate the production of mitochondria. The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics